Abstract
There have been marked advances in the understanding and treatment of Turner syndrome since its initial description in 1938. Greater knowledge of the heterogeneity of phenotypes, early treatment interventions with growth hormone and hormonal replacement, the risks of reproduction, spontaneous and assisted, and the long-term health of women with Turner syndrome has been achieved in the interim. But many perplexing ethical and clinical issues persist.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
